Shares of Annovis Bio, Inc. (NYSE:ANVS – Get Free Report) have earned a consensus recommendation of “Buy” from the six ratings firms that are presently covering the firm, MarketBeat Ratings reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results